These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38397958)

  • 41. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?
    van Blitterswijk M; DeJesus-Hernandez M; Rademakers R
    Curr Opin Neurol; 2012 Dec; 25(6):689-700. PubMed ID: 23160421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci.
    He F; Jones JM; Figueroa-Romero C; Zhang D; Feldman EL; Goutman SA; Meisler MH; Callaghan BC; Todd PK
    Neurol Genet; 2016 Jun; 2(3):e71. PubMed ID: 27274540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.
    Sattler R; Traynor BJ; Robertson J; Van Den Bosch L; Barmada SJ; Svendsen CN; Disney MD; Gendron TF; Wong PC; Turner MR; Boxer A; Babu S; Benatar M; Kurnellas M; Rohrer JD; Donnelly CJ; Bustos LM; Van Keuren-Jensen K; Dacks PA; Sabbagh MN;
    Neurol Ther; 2023 Dec; 12(6):1821-1843. PubMed ID: 37847372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
    Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
    J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia.
    Henden L; Fearnley LG; Grima N; McCann EP; Dobson-Stone C; Fitzpatrick L; Friend K; Hobson L; Chan Moi Fat S; Rowe DB; D'Silva S; Kwok JB; Halliday GM; Kiernan MC; Mazumder S; Timmins HC; Zoing M; Pamphlett R; Adams L; Bahlo M; Blair IP; Williams KL
    Sci Adv; 2023 May; 9(18):eade2044. PubMed ID: 37146135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
    Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
    Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.
    Majounie E; Renton AE; Mok K; Dopper EG; Waite A; Rollinson S; Chiò A; Restagno G; Nicolaou N; Simon-Sanchez J; van Swieten JC; Abramzon Y; Johnson JO; Sendtner M; Pamphlett R; Orrell RW; Mead S; Sidle KC; Houlden H; Rohrer JD; Morrison KE; Pall H; Talbot K; Ansorge O; ; ; ; Hernandez DG; Arepalli S; Sabatelli M; Mora G; Corbo M; Giannini F; Calvo A; Englund E; Borghero G; Floris GL; Remes AM; Laaksovirta H; McCluskey L; Trojanowski JQ; Van Deerlin VM; Schellenberg GD; Nalls MA; Drory VE; Lu CS; Yeh TH; Ishiura H; Takahashi Y; Tsuji S; Le Ber I; Brice A; Drepper C; Williams N; Kirby J; Shaw P; Hardy J; Tienari PJ; Heutink P; Morris HR; Pickering-Brown S; Traynor BJ
    Lancet Neurol; 2012 Apr; 11(4):323-30. PubMed ID: 22406228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unraveling the Role of RNA Mediated Toxicity of
    Kumar V; Hasan GM; Hassan MI
    Front Neurosci; 2017; 11():711. PubMed ID: 29326544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ATXN2 polyQ intermediate repeats are a modifier of ALS survival.
    Chiò A; Calvo A; Moglia C; Canosa A; Brunetti M; Barberis M; Restagno G; Conte A; Bisogni G; Marangi G; Moncada A; Lattante S; Zollino M; Sabatelli M; Bagarotti A; Corrado L; Mora G; Bersano E; Mazzini L; D'Alfonso S;
    Neurology; 2015 Jan; 84(3):251-8. PubMed ID: 25527265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease.
    Rosas I; Martínez C; Clarimón J; Lleó A; Illán-Gala I; Dols-Icardo O; Borroni B; Almeida MR; van der Zee J; Van Broeckhoven C; Bruni AC; Anfossi M; Bernardi L; Maletta R; Serpente M; Galimberti D; Scarpini E; Rossi G; Caroppo P; Benussi L; Ghidoni R; Binetti G; Nacmias B; Sorbi S; Piaceri I; Bagnoli S; Antonell A; Sánchez-Valle R; De la Casa-Fages B; Grandas F; Diez-Fairen M; Pastor P; Ferrari R; Álvarez V; Menéndez-González M
    Neurobiol Aging; 2020 Mar; 87():139.e1-139.e7. PubMed ID: 31810584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of CACNA1A CAG repeat lengths in patients with familial ALS.
    Brenner D; Müller K; Gastl R; Gorges M; Otto M; Pinkhardt EH; Kassubek J; Weishaupt JH; Ludolph AC
    Neurobiol Aging; 2019 Feb; 74():235.e5-235.e8. PubMed ID: 30342765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.
    Byrne S; Elamin M; Bede P; Shatunov A; Walsh C; Corr B; Heverin M; Jordan N; Kenna K; Lynch C; McLaughlin RL; Iyer PM; O'Brien C; Phukan J; Wynne B; Bokde AL; Bradley DG; Pender N; Al-Chalabi A; Hardiman O
    Lancet Neurol; 2012 Mar; 11(3):232-40. PubMed ID: 22305801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
    Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.
    Le Ber I; Camuzat A; Guillot-Noel L; Hannequin D; Lacomblez L; Golfier V; Puel M; Martinaud O; Deramecourt V; Rivaud-Pechoux S; Millecamps S; Vercelletto M; Couratier P; Sellal F; Pasquier F; Salachas F; Thomas-Antérion C; Didic M; Pariente J; Seilhean D; Ruberg M; Wargon I; Blanc F; Camu W; Michel BF; Berger E; Sauvée M; Thauvin-Robinet C; Mondon K; Tournier-Lasserve E; Goizet C; Fleury M; Viennet G; Verpillat P; Meininger V; Duyckaerts C; Dubois B; Brice A
    J Alzheimers Dis; 2013; 34(2):485-99. PubMed ID: 23254636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Dols-Icardo O; García-Redondo A; Rojas-García R; Sánchez-Valle R; Noguera A; Gómez-Tortosa E; Pastor P; Hernández I; Esteban-Pérez J; Suárez-Calvet M; Antón-Aguirre S; Amer G; Ortega-Cubero S; Blesa R; Fortea J; Alcolea D; Capdevila A; Antonell A; Lladó A; Muñoz-Blanco JL; Mora JS; Galán-Dávila L; Rodríguez De Rivera FJ; Lleó A; Clarimón J
    Hum Mol Genet; 2014 Feb; 23(3):749-54. PubMed ID: 24057670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Analysis of
    Trojsi F; Siciliano M; Femiano C; Santangelo G; Lunetta C; Calvo A; Moglia C; Marinou K; Ticozzi N; Ferro C; Scialò C; Sorarù G; Conte A; Falzone YM; Tortelli R; Russo M; Sansone VA; Chiò A; Mora G; Silani V; Volanti P; Caponnetto C; Querin G; Sabatelli M; Riva N; Logroscino G; Messina S; Fasano A; Monsurrò MR; Tedeschi G; Mandrioli J
    Front Neurosci; 2019; 13():485. PubMed ID: 31156370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
    Van Damme P; Veldink JH; van Blitterswijk M; Corveleyn A; van Vught PW; Thijs V; Dubois B; Matthijs G; van den Berg LH; Robberecht W
    Neurology; 2011 Jun; 76(24):2066-72. PubMed ID: 21562247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
    J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.